# Commission Decision of 23 February 2005 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2004 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2005) 293) (Only the Czech, Danish, Dutch, English, Estonian, Finnish, French, German, Italian, Portuguese, Slovenian and Spanish texts are authentic) (Text with EEA relevance) (2005/171/EC), Annex III: ESSENTIAL LABORATORY USES

Extent: E+W+S+N.I.

Quota of controlled substances of Group I and II that may be used for laboratory and analytical uses, are allocated to:
Agfa-Gevaert (BE)
Bie & Berntsen (DK)
Butterworth Laboratories (UK)
Biosolve (NL)
Carl Roth (DE)
Elcom Group (CZ)
Environnement SA (FR)
Honeywell Specialty Chemicals (DE)
Ineos Fluor (UK)
Katholieke Universiteit Leuven (BE)
LGC Promochem (DE)
Mallinckrodt Baker (NL)
Merck KGaA (DE)
Mikro + Polo (SI)
Panreac Química (ES)
SDS Solvants (FR)
Sanolabor (SI)
Sigma Aldrich Chemie (DE)
Sigma Aldrich Chimie (FR)
Sigma Aldrich Company (UK)
University Of Technology Vienna (AT)
Ya Kemia Oy — Sigma Aldrich (FI)

---
Source: https://www.legislation.gov.uk/eudn/2005/171/annex/III (the official version)
Page: https://openlegislation.uk/eu-decision-2005-171/annex-III
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.